Lawmaker accuses Amgen of placing profits above patients with dosing for a cancer drug

AU.S. lawmaker is accusing Amgen of “putting profits before patients” over its decision to continue marketing a high dose of a pricey cancer treatment instead of a lower dose that is less expensive and not as toxic to patients.